Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$19.7M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 15,580 | $495.38 | $7.7M | -12.8% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 3,498 | $494.33 | $1.7M | -2.8% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,520 | $493.29 | $1.2M | -2.0% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 949 | $491.30 | $466.2K | -0.7% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,725 | $490.54 | $1.3M | -2.1% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 460 | $489.32 | $225.1K | -0.4% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 3,278 | $488.27 | $1.6M | -2.4% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,510 | $487.13 | $1.2M | -1.8% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 240 | $482.84 | $115.9K | -0.2% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 120 | $481.50 | $57.8K | <0.1% | Open the original filing on SEC.gov |
| Feb 27 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 400 | $479.75 | $191.9K | -0.3% | Open the original filing on SEC.gov |
| Feb 24 | VRTX | Vertex Pharmaceuticals… | FTAX | 4,981 | $485.11 | $2.4M | -3.5% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX | 6,554 | $483.75 | $3.2M | -4.4% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT | 16,326 | — | — | +12.2% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX | 13,041 | $487.76 | $6.4M | -8.9% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX | 8,297 | $468.41 | $3.9M | -5.4% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 11,885 | — | — | +8.3% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 26,972 | — | — | +23.3% | Open the original filing on SEC.gov |